Literature DB >> 26792552

Brain intra- and extracellular sodium concentration in multiple sclerosis: a 7 T MRI study.

Maria Petracca1, Roxana O Vancea2, Lazar Fleysher3, Laura E Jonkman4, Niels Oesingmann5, Matilde Inglese6.   

Abstract

Intra-axonal accumulation of sodium ions is one of the key mechanisms of delayed neuro-axonal degeneration that contributes to disability accrual in multiple sclerosis. In vivo sodium magnetic resonance imaging studies have demonstrated an increase of brain total sodium concentration in patients with multiple sclerosis, especially in patients with greater disability. However, total sodium concentration is a weighted average of intra- and extra-cellular sodium concentration whose changes reflect different tissue pathophysiological processes. The in vivo, non-invasive measurement of intracellular sodium concentration is quite challenging and the few applications in patients with neurological diseases are limited to case reports and qualitative assessments. In the present study we provide first evidence of the feasibility of triple quantum filtered (23)Na magnetic resonance imaging at 7 T, and provide in vivo quantification of global and regional brain intra- and extra-cellular sodium concentration in 19 relapsing-remitting multiple sclerosis patients and 17 heathy controls. Global grey matter and white matter total sodium concentration (respectively P < 0.05 and P < 0.01), and intracellular sodium concentration (both P < 0.001) were higher while grey matter and white matter intracellular sodium volume fraction (indirect measure of extracellular sodium concentration) were lower (respectively P = 0.62 and P < 0.001) in patients compared with healthy controls. At a brain regional level, clusters of increased total sodium concentration and intracellular sodium concentration and decreased intracellular sodium volume fraction were found in several cortical, subcortical and white matter regions when patients were compared with healthy controls (P < 0.05 family-wise error corrected for total sodium concentration, P < 0.05 uncorrected for multiple comparisons for intracellular sodium concentration and intracellular sodium volume fraction). Measures of total sodium concentration and intracellular sodium volume fraction, but not measures of intracellular sodium concentration were correlated with T2-weighted and T1-weighted lesion volumes (0.05 < P < 0.01) and with Expanded Disability Status Scale (P < 0.05). Thus, suggesting that while intracellular sodium volume fraction decrease could reflect expansion of extracellular space due to tissue loss, intracellular sodium concentration increase could reflect neuro-axonal metabolic dysfunction.
© The Author (2016). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  intra-cellular and extra-cellular sodium concentration; relapsing-remitting multiple sclerosis; sodium imaging; ultra-high field MRI

Mesh:

Substances:

Year:  2016        PMID: 26792552     DOI: 10.1093/brain/awv386

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  33 in total

Review 1.  The Role of Advanced Magnetic Resonance Imaging Techniques in Multiple Sclerosis Clinical Trials.

Authors:  Kedar R Mahajan; Daniel Ontaneda
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

2.  Cortical grey matter sodium accumulation is associated with disability and secondary progressive disease course in relapse-onset multiple sclerosis.

Authors:  Wallace J Brownlee; Bhavana Solanky; Ferran Prados; Marios Yiannakas; Patricia Da Mota; Frank Riemer; Manuel Jorge Cardoso; Sebastian Ourselin; Xavier Golay; Claudia Gandini Wheeler-Kingshott; Olga Ciccarelli
Journal:  J Neurol Neurosurg Psychiatry       Date:  2019-04-04       Impact factor: 10.154

Review 3.  The role of glial-neuronal metabolic cooperation in modulating progression of multiple sclerosis and neuropathic pain.

Authors:  Rachel R Robinson; Alina K Dietz; Asif M Maroof; Reto Asmis; Thomas G Forsthuber
Journal:  Immunotherapy       Date:  2019-02       Impact factor: 4.196

Review 4.  Clinical applications of ultra-high field magnetic resonance imaging in multiple sclerosis.

Authors:  Matilde Inglese; Lazar Fleysher; Niels Oesingmann; Maria Petracca
Journal:  Expert Rev Neurother       Date:  2018-01-30       Impact factor: 4.618

Review 5.  Quantitative sodium MR imaging: A review of its evolving role in medicine.

Authors:  Keith R Thulborn
Journal:  Neuroimage       Date:  2016-11-24       Impact factor: 6.556

6.  Modeling of sustained spontaneous network oscillations of a sexually dimorphic brainstem nucleus: the role of potassium equilibrium potential.

Authors:  Daniel Hartman; Dávid Lehotzky; Iulian Ilieş; Mariana Levi; Günther K H Zupanc
Journal:  J Comput Neurosci       Date:  2021-05-25       Impact factor: 1.621

7.  Multipulse sodium magnetic resonance imaging for multicompartment quantification: Proof-of-concept.

Authors:  Alina Gilles; Armin M Nagel; Guillaume Madelin
Journal:  Sci Rep       Date:  2017-12-12       Impact factor: 4.379

8.  Activity of NaV1.2 promotes neurodegeneration in an animal model of multiple sclerosis.

Authors:  Benjamin Schattling; Walid Fazeli; Birgit Engeland; Yuanyuan Liu; Holger Lerche; Dirk Isbrandt; Manuel A Friese
Journal:  JCI Insight       Date:  2016-11-17

Review 9.  Imaging as an Outcome Measure in Multiple Sclerosis.

Authors:  Daniel Ontaneda; Robert J Fox
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

10.  Brain microstructural and metabolic alterations detected in vivo at onset of the first demyelinating event.

Authors:  Sara Collorone; Ferran Prados; Baris Kanber; Niamh M Cawley; Carmen Tur; Francesco Grussu; Bhavana S Solanky; Marios Yiannakas; Indran Davagnanam; Claudia A M Gandini Wheeler-Kingshott; Frederik Barkhof; Olga Ciccarelli; Ahmed T Toosy
Journal:  Brain       Date:  2021-06-22       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.